13F reference period
Q3 2026
CUSIP: 29384C108
13F reference period
Q3 2026
Institutions Reporting
90
Shares (Excl. Options)
Price
$6.35
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 90 institutions filings for Q3 2026.
Security key
29384C108
13F reference period
Q3 2026
13F holders
90
13D/G owners
7
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 29384C108:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 5AM Ventures V, L.P. | 11% | $25,485,387 | 4,123,849 | Kush Parmar | 14 Nov 2025 | |||
| MPM BioVentures 2014, L.P. | 9.9% | $28,205,935 | 3,885,115 | ANSBERT GADICKE | 08 Sep 2026 | |||
| ROCHE FINANCE LTD | 6.9% | $23,019,270 | 2,569,115 | Roche Finance Ltd | 31 Dec 2024 | |||
| BlackRock, Inc. | 5.3% | $17,691,090 | 1,974,452 | BlackRock, Inc. | 31 Dec 2024 | |||
| JANUS HENDERSON GROUP PLC | 4% | -27% | $9,964,391 | -$3,932,443 | 1,521,281 | -28% | JANUS HENDERSON GROUP PLC | 30 Jun 2025 |
| TCG Crossover GP I, LLC | 2.7% | -46% | $7,803,293 | -$6,308,359 | 1,060,230 | -45% | TCG Crossover GP I, LLC | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.9% | -84% | $2,091,051 | -$12,800,322 | 360,526 | -86% | T. Rowe Price Associates, Inc. | 30 Sep 2025 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 13% | 5,072,730 | 0.15% | $32,211,836 | |
| 5AM Venture Management, LLC | 9.6% | 3,784,650 | 8.1% | $24,032,528 | |
| Merck & Co., Inc. | 4.4% | 1,739,768 | 1.3% | $11,047,527 | |
| Trails Edge Capital Partners, LP | 3.6% | 1,428,440 | 1.3% | $9,070,594 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.2% | 1,269,634 | 0% | $8,062,176 | |
| TCG Crossover Management, LLC | 2.7% | 1,060,230 | 0.19% | $6,732,461 | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.4% | 954,419 | 0% | $6,060,561 | |
| StepStone Group LP | 1.9% | 761,277 | 0.34% | $4,834,109 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 708,490 | 0% | $4,499,856 | |
| STATE STREET CORP | 1.5% | 589,101 | 0% | $3,740,791 | |
| DIMENSIONAL FUND ADVISORS LP | 0.88% | 344,005 | 0% | $2,184,119 | |
| GOLDMAN SACHS GROUP INC | 0.76% | 298,172 | 0% | $1,893,394 | |
| Lynx1 Capital Management LP | 0.71% | 278,606 | 0.27% | $1,769,148 | |
| J. Goldman & Co LP | 0.68% | 268,081 | 0.06% | $1,702,314 | |
| GSA CAPITAL PARTNERS LLP | 0.67% | 262,682 | 0.1% | $1,668,000 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.67% | 261,475 | 0% | $1,660,366 | |
| Longaeva Partners L.P. | 0.58% | 226,520 | 0.04% | $1,438,402 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.51% | 199,200 | 0% | $1,264,920 | |
| VANGUARD FIDUCIARY TRUST CO | 0.46% | 179,872 | 0% | $1,142,187 | |
| Quantinno Capital Management LP | 0.42% | 165,752 | 0% | $1,052,525 | |
| BANK OF AMERICA CORP /DE/ | 0.38% | 150,489 | 0% | $955,605 | |
| Qube Research & Technologies Ltd | 0.38% | 150,225 | 0% | $953,929 | |
| Woodline Partners LP | 0.37% | 145,600 | 0% | $924,560 | |
| Trexquant Investment LP | 0.36% | 139,918 | 0.01% | $888,479 | |
| TWO SIGMA INVESTMENTS, LP | 0.28% | 111,489 | 0% | $707,955 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 23,148,846 | $146,978,767 | -$370,422 | $6.35 | 90 |
| 2026 Q2 | 29,052,007 | $213,997,599 | +$23,782,839 | $7.36 | 127 |
| 2026 Q1 | 25,477,255 | $321,439,067 | +$9,380,200 | $12.62 | 118 |
| 2025 Q4 | 24,428,116 | $250,955,377 | +$6,143,063 | $10.28 | 113 |
| 2025 Q3 | 28,408,651 | $164,766,270 | -$9,410,304 | $5.80 | 114 |
| 2025 Q2 | 29,583,750 | $198,790,015 | -$4,881,409 | $6.72 | 105 |
| 2025 Q1 | 30,241,830 | $274,509,238 | -$4,478,805 | $9.04 | 110 |
| 2024 Q4 | 30,637,008 | $529,755,566 | +$9,629,460 | $17.29 | 102 |
| 2024 Q3 | 30,099,996 | $481,057,545 | +$6,089,620 | $15.98 | 97 |
| 2024 Q2 | 29,668,185 | $422,803,373 | +$52,052,901 | $14.25 | 82 |
| 2024 Q1 | 26,027,444 | $368,797,900 | -$3,772,264 | $14.17 | 76 |
| 2023 Q4 | 26,281,861 | $396,641,035 | +$3,492,844 | $15.09 | 62 |
| 2023 Q3 | 26,035,608 | $411,375,608 | +$4,515,692 | $15.80 | 55 |
| 2023 Q2 | 25,751,810 | $389,877,766 | +$13,317,282 | $15.14 | 56 |
| 2023 Q1 | 24,900,040 | $361,043,649 | +$2,708,627 | $14.50 | 53 |
| 2022 Q4 | 24,715,588 | $334,178,958 | +$2,434,963 | $13.52 | 46 |
| 2022 Q3 | 24,517,008 | $386,369,092 | -$2,728,204 | $15.76 | 33 |
| 2022 Q2 | 24,778,477 | $301,833,417 | -$12,927,920 | $12.18 | 35 |
| 2022 Q1 | 25,876,494 | $242,821,140 | +$2,263,033 | $9.39 | 48 |
| 2021 Q4 | 24,861,440 | $425,110,000 | +$413,748,000 | $17.12 | 45 |